Core Laboratories N.V. (NYSE:CLB) Given Price Target Of $122.666


As per Core Laboratories N.V. (NYSE:CLB)’s news release on 2016-04-15, its shareholders will get cash dividend of $0.55 per share. The recent press release updated on the record date and payout date, which stands at 2016-05-04 and 2016-05-24, respectively.

The stock of Core Laboratories N.V. (NYSE:CLB) will commence trading ex-dividend from 2016-05-02, until which the shareholders are compelled to keep the holdings so as to qualify for the dividend. Evaluating the dividend distribution mode, it was noted that last year Core Laboratories N.V. (NYSE:CLB) disbursed $2.2 in dividend compared to distribution of $2, a year ago. It highlights a sharp difference in cash payouts of the two years. This shows a major deviation of 10%.

The past track record of five years substantiates that the average payout of Core Laboratories N.V. (NYSE:CLB) stands at $1.52, implying 19.8413% growth. The company recorded earnings of $0.82 a share in the preceding fiscal.

The interim price target for Core Laboratories N.V. (NYSE:CLB) is set at $122.666. This level is the mean price reached by averaging the stock views of 9 analysts. All these are top brokerages of Wall Street and trail the company’s performance regularly. The best price estimate is seen at $150 and the lowest level is established at 98. This broad range highlights a standard deviation of $16.17 in reported estimates.

AlphaOne has allotted A sentiment score of 0 to Core Laboratories N.V. (NYSE:CLB) while impact score assigned is 83 as on as on 2016-07-09.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 8 times, 1 visits today)